We serve Chemical Name:tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate CAS:1256360-03-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
CAS.NO:1256360-03-8
Synonyms:1-BOC-7-Methylindole-3-boronic acid, pinacol ester;1-BOC-7-Methylindole-3-boronic acid,pinacol ester
Molecular Formula:C20H28BNO4
Molecular Weight:357.25200
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.69000
Exact Mass:357.21100
LogP:4.03210
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-BOC-7-Methylindole-3-boronic acid, pinacol ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-BOC-7-Methylindole-3-boronic acid,pinacol ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-BOC-7-Methylindole-3-boronic acid,pinacol ester Use and application,1-BOC-7-Methylindole-3-boronic acid, pinacol ester technical grade,usp/ep/jp grade.
Related News: First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate supplier Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs. tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate vendor Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. tert-Butyl 7-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.
